Jarrow Formulas Women's Fem-Dophilus®
Product Details
Fem-Dophilus® contains two patented and clinically documented probiotic strains, Lactobacillus rhamnosus, GR-1® and Lactobacillus reuteri, RC-14®, discovered and developed by Dr. Gregor Reid and Dr. Andrew Cruse at Urex Biotech. Over 25 years of research supports the oral use of GR-1 and RC-14 to colonize and promote healthy vaginal and urinary tract health. A special manufacturing process protects the probiotic strains in Fem-Dophilus from stomach acid and enhances probiotic bacterial survival to the lower intestine.
GR-1/RC-14 and Vaginal Flora (also called microbiota)
In one of the randomized clinical trials, 75% of women in the GR-1/RC-14 probiotic group experienced significant improvement in vaginal flora composition, while only 34% of women in the placebo (non-probiotic) group experienced similar improvement.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Nutritional Information
Ingredients
Maltodextrin ( Non-GMO , Source ) , Cellulose and Magnesium Stearate (Vegetable Source) . Capsule Consists Of : Hydroxypropylmethylcellulose and Titanium Dioxide ( for Coloring ) .
Allergen Info
Contains Corn and Its Derivatives. Free from Does Not Contain Declaration Obligatory Allergens.
Disclaimer
Actual product packaging and materials may contain additional and/or different ingredient,
nutritional, or proper usage information than the information displayed on our website. You are responsible ... Read More
Product Reviews
QFC is not responsible for the content provided in customer ratings and reviews. For more information, visit our Terms and Conditions.